Sanofi denied injunction in injector pen patent dispute

Healthcare 2018-12-19 11:26 pm By Cat Fredenburgh | Melbourne

Please login to bookmark

A judge has denied Sanofi’s bid to block Alphapharm from listing its insulin injector pen on the Pharmaceutical Benefit Scheme, saying Sanofi has not established a strong enough case of infringement to justify granting the injunction.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au